Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 1,500 | 1,561 | 430 | 1,107 | 743 |
| Cost of Goods | 941 | 977 | 300 | 726 | 486 |
| Gross Profit | 560 | 584 | 150 | 381 | 258 |
| Operating Expenses | 5,088 | 7,245 | 4,980 | 3,638 | 5,586 |
| Operating Income | -3,587 | -5,684 | -4,550 | -2,531 | -4,843 |
| Interest Expense | 343 | 227 | 180 | 163 | 159 |
| Other Income | -31 | 7 | 20 | 5 | 107 |
| Pre-tax Income | -3,961 | -5,904 | -4,710 | -2,689 | -4,895 |
| Net Income Continuous | -3,961 | -5,904 | -4,710 | -2,689 | -4,895 |
| Net Income | $-3,961 | $-5,904 | $-4,710 | $-2,689 | $-4,895 |
| EPS Basic Total Ops | -0.43 | -0.64 | -0.54 | -0.46 | -0.83 |
| EPS Basic Continuous Ops | -0.43 | -0.64 | -0.53 | -0.46 | -0.83 |
| EPS Diluted Total Ops | -0.43 | -0.64 | -0.54 | -0.46 | -0.83 |
| EPS Diluted Continuous Ops | -0.43 | -0.64 | -0.53 | -0.46 | -0.83 |
| EBITDA(a) | $-3,494 | $-5,597 | $-4,473 | $-2,445 | $-4,741 |